IRIS
SOLIMANDO, ANTONIO GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.334
AS - Asia 3.217
EU - Europa 2.548
SA - Sud America 858
AF - Africa 169
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.135
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.191
SG - Singapore 1.484
BR - Brasile 755
CN - Cina 671
IT - Italia 623
HK - Hong Kong 477
RU - Federazione Russa 438
SE - Svezia 411
DE - Germania 331
VN - Vietnam 204
FR - Francia 183
GB - Regno Unito 175
FI - Finlandia 91
CA - Canada 78
ID - Indonesia 76
IN - India 75
CI - Costa d'Avorio 67
PL - Polonia 50
MX - Messico 42
NL - Olanda 40
BD - Bangladesh 38
BE - Belgio 37
AR - Argentina 35
CZ - Repubblica Ceca 35
JP - Giappone 33
ZA - Sudafrica 33
ES - Italia 30
AT - Austria 27
TR - Turchia 27
KR - Corea 23
EG - Egitto 19
UA - Ucraina 18
EC - Ecuador 17
LT - Lituania 17
IQ - Iraq 15
AE - Emirati Arabi Uniti 13
JO - Giordania 13
VE - Venezuela 13
CL - Cile 12
MA - Marocco 11
UZ - Uzbekistan 11
TN - Tunisia 10
IE - Irlanda 9
PK - Pakistan 9
CO - Colombia 8
IR - Iran 8
PY - Paraguay 8
KE - Kenya 7
SA - Arabia Saudita 7
AU - Australia 6
CH - Svizzera 6
DK - Danimarca 4
DZ - Algeria 4
MY - Malesia 4
NP - Nepal 4
PA - Panama 4
PE - Perù 4
UY - Uruguay 4
HU - Ungheria 3
KW - Kuwait 3
LB - Libano 3
NO - Norvegia 3
PS - Palestinian Territory 3
QA - Qatar 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
GM - Gambi 2
HR - Croazia 2
HT - Haiti 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
NI - Nicaragua 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
ZM - Zambia 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BW - Botswana 1
CG - Congo 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
Totale 13.120
Salva come PNG Salva come JPEG
Città #
Ashburn 927
Singapore 786
Chandler 605
Fairfield 570
Hong Kong 473
Nyköping 341
Woodbridge 303
Houston 253
Seattle 250
Beijing 249
Cambridge 233
New York 203
Ann Arbor 201
Bari 184
Wilmington 176
Los Angeles 169
Dallas 132
Munich 114
Dearborn 100
Roxbury 93
Lawrence 92
Marseille 81
Des Moines 69
Abidjan 67
Jakarta 66
São Paulo 66
Brooklyn 62
Ho Chi Minh City 62
Moscow 60
Rome 60
Chicago 51
Buffalo 50
Helsinki 47
San Diego 45
London 44
Nanjing 44
Santa Clara 44
Frankfurt am Main 41
Boardman 40
Inglewood 40
Dong Ket 39
Hanoi 38
Brussels 37
Turku 36
Falkenstein 32
Tokyo 31
Warsaw 30
Council Bluffs 29
Toronto 29
Denver 28
Brno 26
Orem 26
Stockholm 26
Milan 25
Jacksonville 24
Johannesburg 24
Paris 23
Redwood City 23
Nuremberg 22
Poplar 22
Chennai 21
Montreal 21
Phoenix 20
Boston 19
Princeton 19
The Dalles 19
Washington 19
Guangzhou 18
Columbus 17
Manchester 17
Rio de Janeiro 17
Campinas 16
Leawood 16
Salt Lake City 16
Shanghai 15
Augusta 14
Curitiba 14
San Francisco 14
Shenyang 14
Tampa 14
Amsterdam 13
Belo Horizonte 13
Brasília 13
Kunming 13
Mexico City 13
Pune 13
Amman 12
Grafing 12
Atlanta 11
Cairo 11
Dhaka 11
Nanchang 11
Salvador 11
Torrile 11
Ankara 10
Hefei 10
Jinan 10
Porto Alegre 10
Roubaix 10
Tashkent 10
Totale 8.631
Salva come PNG Salva come JPEG
Nome #
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 272
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression 216
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 199
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 194
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 185
B-Cell Therapies in Relapsing Remitting and Primary Progressive Multiple Sclerosis: A Short Clinical Review 167
The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein 163
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 163
JAM-A as a Prognostic Factor and New Therapeutic Target in Multiple Myeloma 163
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer 159
Targeting B-cell non Hodgkin lymphoma: New and old tricks 158
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 158
Microenvironment drug resistance in multiple myeloma: Emerging new players 157
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study 157
Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma 155
HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma 150
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 144
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 144
Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review 143
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 140
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma 138
Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment 137
A multiple myeloma that progressed as type i cryoglobulinemia with skin ulcers and foot necrosis: A case report 137
BL1391: an established cell line from a human malignant peripheral nerve sheath tumor with unique genomic features 127
Bortezomib treatment modulates autophagy in multiple myeloma 126
Dyspnea, Fatigue, and Generalized Weakness in a 67-Year-Old Man: Approach to the Patient Between Guidelines and Clinical Judgment 125
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 124
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 122
Emerging Concepts in Acute Heart Failure: From the Pathophysiology to the Clinical Case Based Approach 121
Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review 120
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 118
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs 118
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 116
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib 115
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target 114
A comprehensive biological and clinical perspective can drive a patient-tailored approach to multiple myeloma: Bridging the gaps between the plasma cell and the neoplastic niche 114
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF‐MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement 113
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 113
Angiogenesis and Antiangiogenesis in Multiple Myeloma 112
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 111
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 109
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer 107
RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS 107
Actors on the scene: Immune cells in the myeloma niche 105
CIC-Mutation As a Potential Molecular Mechanism of Acquired Resistance to Combined BRAF/MEK Inhibition in CNS Multiple Myeloma 105
Amyloid heart involvement lead a fast fatal evolution a healthy woman: a case report 101
Antibiotic treatment in vasculitic leg ulcers: a single center experience 99
Imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of covid-19 99
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 99
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery 98
Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research 97
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 97
Sonography of superficial lymph nodes in malignant lymphomas. Data from our case series. 96
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine 96
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? 94
Proangiogenic effect of bone marrow fibroblasts in patients with multiple myeloma 94
Fever, cough and breathlessness in a patient with digeorge syndrome 93
Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm 92
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study 90
Efficacy and safety of benralizumab in eosinophilic granulomatosis with polyangiitis: A meta‐analysis of eight studies 87
Real-life experience with omalizumab in chronic spontaneous urticaria. 87
Rituximab induces a reduction of lymphocyte CD3+ activated in patients with autoimmune diseases 85
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 85
Two-year follow-up after drug desensitization in mucopolysaccharidosis 82
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 82
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 81
Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion 80
A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions 80
Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma 80
A Challenging Case of Visceral Leishmaniasis 79
Rituximab use in autoimmune diseases: a single center experience. 79
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs 79
An atypical presentation of intestinal neuroendocrine tumor. 78
null 77
Immune system and bone microenvironment: rationale for targeted cancer therapies 76
Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma: Could Surgery Represent a Therapeutic Option? 76
Prognostic role of neoplastic markers in Takotsubo syndrome 76
Telemedicine DSS-AI Multi Level Platform for Monoclonal Gammopathy Assistance 76
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 73
Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting 72
Difference in growth hormone response to growth hormone-releasing hormone (GHRH) testing following GHRH subacute treatment in normal aging and growth hormone-deficient adults: Possible perspectives for therapeutic use of GHRH or its analogs in elderly subjects? 72
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment 72
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples 70
Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 70
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 69
Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow 69
Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer – Narrowing the Gap Between Bench and Bedside 69
Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy 68
Gene Expression Comparison between Alcohol-Exposed Versus Not Exposed Pancreatic Ductal Adenocarcinoma Patients Reveals a Peculiar TGFβ-Related Phenotype: An Exploratory Analysis 67
COVID-19 and the Endocrine System: A Comprehensive Review on the Theme 67
Comprehensive analysis of clinical outcomes, infectious complications and microbiological data in newly diagnosed multiple myeloma patients: a retrospective observational study of 92 subjects 66
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 66
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study 66
Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia: a randomized trial 66
A Markov model for estimating the cost-effectiveness of immunotherapy for newly diagnosed multiple myeloma patients 66
Aggressive systemic mastocytosis with the co-occurrence of PRKG2::PDGFRB, KAT6A::NCOA2, and RXRA::NOTCH1 fusion transcripts and a heterozygous RUNX1 frameshift mutation 65
Editorial: Angiogenesis blockade for the treatment of gastrointestinal cancer 65
Genomic profiling at a single center cracks the code in inborn errors of immunity 64
CARDIOVASCULAR RISK SCORE MAY BE USEFUL IN STRATIFY DEATH RISK IN HOSPITALIZED COVID19 PATIENTS 64
Targeting the immune microenvironment in Waldenström Macroglobulinemia via halting the CD40/CD40-ligand axis 63
Totale 10.700
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.979
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.979
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021845 0 0 0 0 0 127 159 130 81 129 90 129
2021/2022941 79 36 30 33 40 84 38 50 76 82 135 258
2022/20231.550 155 220 128 123 145 170 43 186 280 26 50 24
2023/2024866 48 121 54 76 75 258 32 21 20 24 16 121
2024/20253.613 150 57 172 130 134 313 538 355 160 220 522 862
2025/20263.953 1.066 374 498 903 1.019 93 0 0 0 0 0 0
Totale 14.052